Literature DB >> 2212597

The diabetic foot. Soft tissue and bone infection.

B A Lipsky1, R E Pecoraro, L J Wheat.   

Abstract

Diabetic patients, as a consequence of various neurologic, vascular, and metabolic perturbations, are at high risk for developing infections of the soft tissue and bones of the feet. The microbial etiology of soft tissue in infections is best determined by cultures of a tissue curetting or aspiration, rather than a swab. Aerobic gram-positive cocci are the major pathogens in diabetic foot infections; these may be the sole isolate(s) in acute uncomplicated infections, but they are usually accompanied by aerobic gram-negative bacilli or anaerobes in chronic or previously treated infections. Carefully selected patients with mild infections can be treated as outpatients with oral antibiotics, but others require hospitalization and broad-spectrum parenteral antibiotics. Bone infections are frequently diagnosed on the basis of roentgenographs and nuclear medicine scans, but these methods are often inaccurate, and bone cultures should be obtained whenever possible.

Entities:  

Mesh:

Year:  1990        PMID: 2212597

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  27 in total

1.  A Current Approach to Diabetic Foot Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

Review 2.  Diabetic foot infections: stepwise medical and surgical management.

Authors:  David G Armstrong; Benjamin A Lipsky
Journal:  Int Wound J       Date:  2004-06       Impact factor: 3.315

3.  Magnetic resonance imaging of diabetic foot complications.

Authors:  Keynes T A Low; Wilfred C G Peh
Journal:  Singapore Med J       Date:  2015-01       Impact factor: 1.858

4.  Optimal management of uncomplicated skin and skin structure infections of the lower extremity.

Authors:  Warren S Joseph
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

5.  From ulcer to infection: an update on clinical practice and adjunctive treatments of diabetic foot ulcers.

Authors:  C Abad; N Safdar
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

6.  Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. The Piperacillin/Tazobactam Skin and Skin Structure Study Group.

Authors:  J S Tan; R M Wishnow; D A Talan; F P Duncanson; C W Norden
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

Review 7.  Optimising antimicrobial therapy in diabetic foot infections.

Authors:  Nalini Rao; Benjamin A Lipsky
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Prevalence of ischemia in diabetic foot infection.

Authors:  Muhammad R Khammash; Khaled A Obeidat
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

9.  Clinico-microbiological study and antibiotic resistance profile of mecA and ESBL gene prevalence in patients with diabetic foot infections.

Authors:  Waqas Nasir Chaudhry; Rabia Badar; Muhsin Jamal; Jason Jeong; Jamal Zafar; Saadia Andleeb
Journal:  Exp Ther Med       Date:  2016-01-14       Impact factor: 2.447

10.  Wound chronicity, inpatient care, and chronic kidney disease predispose to MRSA infection in diabetic foot ulcers.

Authors:  Christopher Yates; Kerry May; Thomas Hale; Bernard Allard; Naomi Rowlings; Amy Freeman; Jessica Harrison; Jane McCann; Paul Wraight
Journal:  Diabetes Care       Date:  2009-07-08       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.